Structure and mechanism of a Type III CRISPR defence DNA nuclease activated by cyclic oligoadenylate. (2020)

First Author: McMahon SA
Attributed to:  Cyclic oligoadenylate signalling - a new type of antiviral response funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-019-14222-x

PubMed Identifier: 31980625

Publication URI: http://europepmc.org/abstract/MED/31980625

Type: Journal Article/Review

Volume: 11

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723